Helena Mazuelas

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Correction: Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.

Correction: Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.

Journal: PloS one
Published: March 10, 2026

Induced pluripotent stem cell-derived models of malignant nerve sheath tumor progression mimic glial to neuro-mesenchymal transition and uncover therapeutic opportunities.

Induced pluripotent stem cell-derived models of malignant nerve sheath tumor progression mimic glial to neuro-mesenchymal transition and uncover therapeutic opportunities.

Journal: Nature communications
Published: August 29, 2025

Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.

Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.

Journal: PloS one
Published: August 07, 2025

Personalized medicine strategy for MPNSTs: using precision oncology on PDOX models to inform tumor boards.

Personalized medicine strategy for MPNSTs: using precision oncology on PDOX models to inform tumor boards.

Journal: Journal of translational medicine
Published: May 15, 2025

Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.

Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2024

iPSC-based merlin-deficient Schwann cell-like spheroids as an in vitro system for studying NF2 pathogenesis.

iPSC-based merlin-deficient Schwann cell-like spheroids as an in vitro system for studying NF2 pathogenesis.

Journal: Genes & diseases
Published: July 24, 2024

Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities.

Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities.

Journal: Molecular oncology
Published: June 16, 2023

Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.

Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.

Journal: JCI insight
Published: January 12, 2023

Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses.

Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses.

Journal: STAR protocols
Published: October 03, 2022

Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis.

Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis.

Journal: iScience
Published: July 26, 2022

Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas.

Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas.

Journal: Cell reports
Published: July 05, 2021

KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.

KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.

Journal: Neuro-oncology advances
Published: July 10, 2020
Showing 1-12 of 16

Last Updated: 09/26/2026